Pediatrix Medical (MD) Invested Capital (2009 - 2026)

Pediatrix Medical has disclosed Invested Capital across 18 years of filings, most recently posting $1.1 billion for Q1 2026.

• In Q1 2026, Invested Capital rose 6.91% year-over-year to $1.1 billion; the TTM figure through Mar 2026 stood at $1.1 billion (up 6.91% YoY), while the FY2025 annual figure was $890.9 million, down 35.26% from the prior year.
• Invested Capital improved to $1.1 billion in Q1 2026, from $890.9 million in the prior quarter.
• Over the last five years, Invested Capital for MD reached as high as $1.5 billion in Q4 2022 and fell as low as $890.9 million in Q4 2025.
• The 5-year median for Invested Capital is $1.1 billion (2025), against an average of $1.1 billion.
• Annual changes were most pronounced in 2022 — Invested Capital jumped 66.51% — and 2025, when it slumped 35.26%.
• A 5-year view of Invested Capital shows it stood at $1.5 billion in 2022, then slipped by 3.77% to $1.5 billion in 2023, then declined by 6.47% to $1.4 billion in 2024, then tumbled by 35.26% to $890.9 million in 2025, then gained by 20.02% to $1.1 billion in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered $1.1 billion, $890.9 million, and $1.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.